NCT07295327Recruiting
Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
Randomized and Comparative Clinical Study on the Lipid-lowering Efficacy and Tolerability of Two Food Supplements in Mild Hypercholesterolemia
Source: ClinicalTrials.gov · Last updated 19 Dec 2025
Brief summary (registry, in English)
The primary outcome is to evaluate the effect of Cynacol on the change in LDL-C levels compared to Metacol after 90 days of supplementation. The secondary outcomes are to evaluate: \- the change of TC, non-HDL cholesterol (non-HDL-C), apolipoprotein B (apoB), Tg, HDL-C levels after 90 days of supplementation with Cynacol compared to Metacol. The safety outcome is collection of the adverse events not related, related or possibly related to the study products.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 8 Dec 2025
- Start date
- 30 Sept 2025
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT07295327
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 30 Sept 2025 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- taking hypolipidemic drugs or supplements that affect lipid metabolism
Other illness
- personal history of cardiovascular disease or equivalent risk factors
- diabetes mellitus
- known thyroid, liver, kidney or muscle diseases
- any medical or surgical condition that makes patient compliance with the study protocol complex or inconsistent
- any known allergy or hypersensitivity to one or more components of the food supplements
Lab values
- Tg levels ≥ 400 mg/dl
Other
- obesity \[body mass index (BMI) ≥ 30 kg/m²\]
Who the study is looking for
- age between 35-70 years
- both genders
- LDL-C levels between 115 and 190 mg/dl
- subjects able to understand the informed consent and sign it before enrollment in the study
Age in the registry: 35 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione IRCCS Policlinico San Matteo Coordinator of this site? Confirm its status | Pavia | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.